Linda Styer

Linda Styer, PhD

Title
Director, Bloodborne Viruses Laboratory
Clinical Assistant Professor, Department of Biomedical Sciences, College of Integrated Health Sciences, University at Albany
Education
PhD, University of California, Davis, CA (2003)
Postdoctoral training: New York State Department of Health, Wadsworth Center
Phone Number
(518) 473-6007

Dr. Linda Styer earned a doctoral degree in medical entomology and a masters degree in epidemiology from the University of California, Davis.  In 2003, she joined the Wadsworth Center, first as a post-doctoral scientist in the Arbovirology Laboratory, and then as a Research Scientist in the Bloodborne Viruses Laboratory.  

The Bloodborne Viruses Laboratory serves as the public health reference laboratory for human immunodeficiency (HIV) and hepatitis C virus (HCV) testing in New York State. Dr. Styer’s research interests include the development of new serologic or molecular diagnostic tests for the detection, quantification, or characterization of bloodborne viruses and the evaluation of FDA approved diagnostic tests and diagnostic testing algorithms. During the COVID-19 pandemic response, the laboratory developed a high-throughput microsphere immunoassay to detect antibodies to SARS-CoV-2 in dried blood spot specimens and then further developed the capabilities of this assay and employed it for use in several surveillance studies.

 

Select Publications
Damjanovic AK, Keyel A, Rock JM, Ehrbar D, Bievenue R, Nemeth KL, Yauney E, Kay DM, Caggana M, Parker MM, Styer LM. Longitudinal analysis of passively and actively acquired SARS-CoV-2 antibodies in infants with repeat newborn screening samples. Sci Rep. 2025; Jul 4;15 (1): 23881. DOI: 10.1038/s41598-025-09140-6
Nemeth, KL, E Yauney, JM Rock, R Bievenue, MM Parker, LM Styer. Use of self-collected dried blood spots and a multiplex microsphere immunoassay to measure IgG antibody response to COVID-19 vaccines. Microbiology Spectrum. 2023; 11 (1): e01336-22. DOI: 10.1128/spectrum.01336-22
Styer LM, Gaynor AM, Parker MM, Bennett SB, Wesolowski LG, Ethridge S, Chavez PR, Sullivan TJ, Fordan S, Wroblewski K. Three Years of Shared Service HIV Nucleic Acid Testing for Public Health Laboratories: Worthwhile for HIV-1 but Not for HIV-2. Sex Transm Dis. 2020; May;47 (5S Suppl 1): S8-S12. DOI: 10.1097/OLQ.0000000000001123
Styer LM, Miller TT, Parker MM. Validation and clinical use of a sensitive HIV-2 viral load assay that uses a whole virus internal control. Journal of Clinical Virology. 2013; 58 (suppl 1): E127-E133.
Styer LM, Sullivan TJ, Parker MM. Evaluation of an alternative supplemental testing strategy for HIV diagnosis by retrospective analysis of clinical HIV testing data. Journal of Clinical Virology. 2011; 52 (Suppl 1): S35-S40.
Full publication listing